Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ARK Innovation ETF (ARKK) vs Axogen Inc (AXGN) Price & Performance

ARK Innovation ETFTrade
Axogen IncTrade

Price performance (Past 24H)

Key statistics

ARK Innovation ETF vs Axogen Inc — how do they compare? ARK Innovation ETF trades at $80.86, while Axogen Inc trades at $48.42 (market cap $2.61B). The key difference: Axogen Inc is trading nearer its 52-week high, ARK Innovation ETF nearer its low. Which is the better fit depends on your goals.

ARKKAXGN
52-Week High
$92.50$48.48
52-Week Low
$63.52$14.16
Market Cap
$2.61B
Sector
Technology
Enterprise Value
$2.52B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ARK Innovation ETF

ARKK trades at $81.51, up 1.3% on the day, with technical indicators showing a bullish trend from moving averages but overbought short-term RSI. The ETF's performance remains challenged by high concentration in speculative growth stocks like Tesla and SpaceX, with no fundamental ratios provided. Recent news highlights Cathie Wood's continued bets on AI and space innovation amid criticism of fees and underperformance versus the S&P 500.

Outlook is cautious due to reliance on a few volatile holdings and premium fees; risks include growth deceleration and market sentiment shifts. Opportunities exist if disruptive bets pay off, but investor patience is required amid potential downside volatility.

Axogen Inc

AXGN trades at $48.53, up 0.64% today, with a bullish technical signal from moving averages and strong analyst support. Q2 2026 revenue grew 23.1% to $69.7M, beating estimates, and full-year guidance was raised to at least $279M. However, the company remains unprofitable with a net income margin of -13.36% and negative ROE, reflecting high SG&A costs relative to revenue.

The outlook is mixed: robust revenue growth and FDA-backed nerve care platform expansion offer upside, but persistent losses and high valuation multiples (P/S 9.57) pose risks. With 84% analyst buy ratings and a $54.33 price target, near-term momentum depends on execution toward profitability amid competitive and reimbursement pressures.

Returns comparison

Trailing returns across standard periods

About ARK Innovation ETF

The fund will invest under normal circumstances primarily (at least 65% of its assets) in domestic and foreign equity securities of companies that are relevant to the fund’s investment theme of disruptive innovation. Its investments in foreign equity securities will be in both developed and emerging markets. The fund may invest in foreign securities listed on foreign exchanges as well as American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs). The fund is non-diversified.

Read more on ARKK

About Axogen Inc

Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.

Read more on AXGN